The international biological drugs market is envisaged to grow at a handsome rate in the next few years. However, it could face challenges in the form of various product parameters, strict regulatory pathways and manufacturing processes, and longer product approvals, although biological drugs have historically shown better approval rates than conventional ones. Additionally, small players could find it difficult to enter the market because of the requirement of high capital expenditure.
This report contains market size and forecasts of Biological Drugs in global, including the following market information:
- Global Biological Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
- Global Biological Drugs Market Sales, 2017-2022, 2023-2028, (K MT)
Global top five Biological Drugs companies in 2021 (%)
The global Biological Drugs market was valued at 291940 million in 2021 and is projected to reach US$ 495400 million by 2028, at a CAGR of 7.8% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Therapeutic Protein Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Biological Drugs include Bristol-Myers Squibb, Eli Lilly, Takeda, Pfizer, Amgen, F. Hoffmann-La Roche, Johnson & Johnson, Merck and Abbott Laboratories, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Biological Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Biological Drugs Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K MT)
Global Biological Drugs Market Segment Percentages, by Type, 2021 (%)
- Therapeutic Protein
- Monoclonal Antibody
- Vaccine
- Others
Global Biological Drugs Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K MT)
Global Biological Drugs Market Segment Percentages, by Application, 2021 (%)
- Hospitals
- Ambulatory Surgical Centers
- Others
Global Biological Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K MT)
Global Biological Drugs Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Biological Drugs revenues in global market, 2017-2022 (Estimated), ($ millions)
- Key companies Biological Drugs revenues share in global market, 2021 (%)
- Key companies Biological Drugs sales in global market, 2017-2022 (Estimated), (K MT)
- Key companies Biological Drugs sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Bristol-Myers Squibb
- Eli Lilly
- Takeda
- Pfizer
- Amgen
- F. Hoffmann-La Roche
- Johnson & Johnson
- Merck
- Abbott Laboratories
- Baxter
- Novartis
- Biogen
- GlaxoSmithKline
